Nasdaq

BioNexus Gene Lab Corp. and Fidelion Diagnostics Announce Landmark Alliance—Touted as a new "DeepSeek Moment" in Precision Oncology

KUALA LUMPUR, Malaysia, July 30, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (“BGLC”, Nasdaq: BGLC) and Fidelion Diagnostics Pte Ltd, a Singaporean company (“Fidelion”) today announced the ...
Seeking Alpha

BioNexus Gene Lab Corp. Files $100 Million Shelf Registration and Establishes $20 Million At-the-Market Program to Advance Strategic Growth Opportunities

KUALA LUMPUR, Malaysia, Nov. 10, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (BGLC) (“BioNexus” or the “Company”), a biotechnology company advancing precision diagnostics and gene-based ...
Benzinga.com

BioNexus Gene Lab Corp. Engages Maxim Group LLC for M&A, Financial Advisory, and Investment Banking Services

BioNexus Gene Lab Corp. Engages Maxim Group LLC for M&A, Financial Advisory, and Investment Banking Services to Enhance Shareholder Value and Strategic Growth KUALA ...